Unitree's STAR Market IPO: The Numbers
On August 15, Unitree Technology's STAR Market subscription opened under code 787036 with:
- Market cap at issuance: 60.993 billion yuan
- P/E ratio: 219.23x
- P/S ratio: 35.89x
- Revenue: 159 million yuan (2023) → 393 million yuan (2024) → 1.699 billion yuan (2025), a 230% three-year CAGR
- Net profit: from -11.15 million yuan to +278 million yuan, with a 16.4% net margin in 2025
- Gross margins: 44.22% → 56.74% → 60.13%, well above the listed-peer average of ~37%
- Unitree shipped 5,500+ humanoid robots in 2025, ranked first globally (Agibot second with 4,000+)
- Yet 73.6% of revenue comes from research and education customers
- Meituan-affiliated investors: 9.65% (largest external holder)
- Sequoia: 7.11%; Matrix Partners: 5.45%; Shunwei: 4.42%
- Alibaba, Tencent, and Ant Group on the register
- China's National Social Security Funds (combinations 601, 502, 109) were allocated 933,400 shares combined
- July 24: Agibot confirmed it is launching a Hong Kong listing
- August 4: Zhipingfang (BrainCo-adjacent robotics firm) reportedly preparing a Hong Kong IPO, potentially starting by 2027
These figures make Unitree the A-share market's "first humanoid robotics stock." For comparison, peer UBTech trades at 19.37x P/S in Hong Kong and Dobot at 20.12x; the industry classification (C34 general equipment manufacturing) carries a static P/E of 38.56x. In other words, Unitree's P/S is roughly 80% higher than peers, and its P/E is about 5.7x the industry average.
The Growth Curve Supporting the Valuation
The IPO prospectus discloses:
This stepped growth trajectory is the physical basis for a 219x P/E to exist at all.
The Line That Splits the Story
2026 H1 guidance projects revenue of 1.052–1.128 billion yuan, up 35.62%–45.41% year-over-year — growth decelerating from 230% to ~40%. Non-recurring net profit is expected to decline 6.43% year-over-year. The company attributes this to "significantly increased R&D and sales expenses." Growth continues, but profits are under pressure first.
This maps directly to the use of proceeds: of the 4.202 billion yuan raised, 2.022 billion yuan (48%) is allocated to an "intelligent robotics model R&D project."
Commercialization Concentration
Founder Wang Xingxing said at the August 7 roadshow: "Current achievements are only a starting point; the embodied intelligence industry as a whole is still at an early stage of development." The G1 sells for 99,000 yuan — over 5x cheaper than Boston Dynamics' Spot. That pricing is Unitree's moat; but "payback in three months in a factory, ten years of use in the home" is the story for the next valuation leg.
A Star-Studded Shareholder Register
The social security fund participation signals that the embodied intelligence track has entered the视野 of national strategic capital. The lottery win rate was 0.01809759% — fewer than 2 in 10,000 investors got an allocation.
Why "Both Glory and a Heavy Burden"
The glory: Unitree sets the industry's valuation anchor — embodied intelligence now has its first pure A-share reference point. The burden: investors will scrutinize every shipment and order with public-company earnings discipline.
The Ministry of Industry and Information Technology projects annual humanoid robot production exceeding 100,000 units in 2026 (versus only ~20,000 in 2025, a 5x jump in one year). Unitree's IPO is the first ticket onto the embodied AI ship, but the next wave of differentiation hinges on whether it can reduce that 73.6% research/education revenue share and build a new consumer/home-scenario growth curve.